Indikationsgebiete
Wir verfügen über umfangreiches Wissen auf den unter-
schiedlichsten Indikationsgebieten:

PHASE I STUDIES (national & international)

  • First in man

  • Pharmacokinetics and pharmacodynamics

  • Food interactions

  • Genotyping

  • Coagulation factors

  • Renal impairment
Team
Qualität
Indikationsgebiete

PHASE II-III B STUDIES (national & international)

Antiinfective drugs

Quinolones (gyrase inhibitors) / cephalosporins / macrolides
and ketolides

  • Exacerbation of chronic bronchitis

  • Acute bronchitis

  • Pneumonia (CAP, HAP)

  • Sepsis

  • Otitis media

  • Tonsillitis

  • Urinary tract infection

  • Maxilliary sinusitis

  • Neutropenia

Asthma

  • Acute asthma

Cardiovascular disease

  • Coronary heart disease

Dementia

  • Vascular dementia

  • Alzheimer's disease

Dermatology

  • Onychomycosis

  • Brittle nail syndrome

HAE


HIV

Metabolic diseases

  • Diabetes mellitus type I

  • Diabetes mellitus type II

  • Impaired glucose tolerance

Multiple sclerosis

  • RRMS

Radiographic contrast media

  • Patient with CAD

Renal impairment

Schizophrenia

Spinal cord injury

Vitamin C

Copyright © 2007 by AMANTEC